Blood pressure lowering medications could be used more widely to prevent migraines

FHS
June 28, 2023
3:54 am

The first known large-scale review of international studies on the positive effect of blood pressure (BP) medicines across all classes in preventing migraine shows these widely available drugs could be used much more widely, at low cost, than is the case with current practice, according to a new paper published today in the journal, Cephalalgia.

Moncef Slaoui joins board at mRNA biotech; Gamida Cell retools with ex-Amryt CEO at the helm

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 22, 2024

Novel biomaterials approach reveals how mechanical forces shape T cell fate

The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of

June 27, 2023

Financial Toxicity of Ovarian Cancer Treatment for Patients

Financial burdens can negatively affect the quality of life for individuals with ovarian cancer, according to the results of a qualitative study presented at the

May 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.